Qishen granules exerts cardioprotective effects on rats with heart failure via regulating fatty acid and glucose metabolism

Chinese Medicine
Kuo GaoWei Wang

Abstract

Qishen granules (QSG) has been applied to treat heart failure (HF) for decades. Our previous transcriptomics study has suggested that Qishen granules (QSG) could regulate the pathways of cardiac energy metabolism in HF, but the specific regulatory mechanism has not yet been clarified. This study was to investigate the potential mechanism of QSG in regulating myocardial fatty acid (FA) and glucose metabolism in a rat model of HF. The model of HF was induced by left anterior descending coronary artery ligation. Cardiac structure and function were assessed by cine magnetic resonance imaging (MRI) and echocardiography. Level of glucose metabolism was non-invasively evaluated by 18F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT). Blood lipid levels were determined by enzymatic analysis. The mitochondrial ultrastructure was observed with a transmission electron microscope. The critical proteins related to FA metabolism, glucose metabolism and mitochondrial function were measured by western blotting. The ANOVA followed by a Fisher's LSD test was used for within-group comparisons. QSG ameliorated cardiac functions and attenuated myocardial remodeling in HF model. The levels of serum TC, TG and LDL-C were s...Continue Reading

References

Apr 3, 2001·Trends in Cardiovascular Medicine·P M Barger, D P Kelly
Jul 25, 2003·The Journal of Experimental Biology·John D PorterGeorgiana Cheng
Sep 18, 2004·Circulation Research·Janice M Huss, Daniel P Kelly
Oct 3, 2006·Cardiovascular Research·Brian N Finck
Sep 28, 2010·Journal of Molecular and Cellular Cardiology·Heinrich Taegtmeyer, William C Stanley
Oct 1, 2010·Journal of Magnetic Resonance Imaging : JMRI·Johannes RieglerMark F Lythgoe
Jan 26, 2012·Seminars in Cell & Developmental Biology·Lars la Cour PoulsenSusanne Mandrup
Nov 30, 2013·Cardiology Clinics·Longjian Liu, Howard J Eisen
Jan 9, 2014·International Journal of Cardiology·Christopher CookDarrel P Francis
Jul 30, 2014·Bioscience, Biotechnology, and Biochemistry·Mina FujitaniKazuo Inoue
Sep 27, 2014·Best Practice & Research. Clinical Endocrinology & Metabolism·Chitoku Toda, Sabrina Diano
Feb 17, 2015·Biochemical and Biophysical Research Communications·Ziyi ZhouDingfang Cai
Feb 26, 2015·American Journal of Physiology. Heart and Circulatory Physiology·Cynthia ZizolaP Christian Schulze
May 21, 2015·Pulmonary Circulation·Sowndramalingam Sankaralingam, Gary D Lopaschuk
Jul 15, 2015·Current Pharmaceutical Design·Arata FukushimaGary D Lopaschuk
Jul 16, 2015·Korean Journal of Radiology : Official Journal of the Korean Radiological Society·Rui YanSijin Li
Mar 5, 2016·Nature Reviews. Cardiology·Boback Ziaeian, Gregg C Fonarow
Jul 2, 2016·British Medical Bulletin·Adam NabeebaccusAjay M Shah
Dec 25, 2016·American Journal of Physiology. Heart and Circulatory Physiology·Satoshi KaimotoSatoaki Matoba
Mar 30, 2017·High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension·Maria Lorenza MuiesanMassimo Salvetti
Apr 2, 2017·The International Journal of Cardiovascular Imaging·Maythem SaeedMark W Wilson
May 13, 2017·Chinese Journal of Integrative Medicine·Ling-Hui LuWei Wang
May 19, 2019·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Zifan ZengWei Wang
Dec 12, 2019·Frontiers in Pharmacology·Wenji LuChun Li

❮ Previous
Next ❯

Methods Mentioned

BETA
electrophoresis

Software Mentioned

mathop
VnmrJ
SPSS
Inveon Research Workplace
OSEM3D
Imagelab
MAP

Related Concepts

Related Feeds

Cardiac Remodeling

Cardiac remodeling in response to a myocardial infarction is characterized by progressive ventricular dilatation, cardiac hypertrophy, fibrosis, and deterioration of cardiac performance. Discover the latest research on Cardiac Remodeling here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.